Home/Filings/4/0001104659-21-081898
4//SEC Filing

Alkon Daniel L. 4

Accession 0001104659-21-081898

CIK 0001571934other

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 1:01 PM ET

Size

13.6 KB

Accession

0001104659-21-081898

Insider Transaction Report

Form 4
Period: 2021-06-14
Alkon Daniel L.
DirectorChief Scientific Officer
Transactions
  • Purchase

    Common Stock, par value $0.0001 per share

    2021-06-14$8.26/sh+10,000$82,60011,484 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.19 to $8.35, inclusive. The reporting person undertakes to provide to Synaptogenix, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

Issuer

Synaptogenix, Inc.

CIK 0001571934

Entity typeother

Related Parties

1
  • filerCIK 0001686138

Filing Metadata

Form type
4
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 1:01 PM ET
Size
13.6 KB